• San Diego’s Acadia Pharmaceuticals Updates Plans for Experimental Parkinson’s Drug

    Updated: 2010-03-10 22:24:45
    Acadia Pharmaceuticals of San Diego and its Canadian partner Biovail are continuing to move ahead with pimavanserin. The experimental drug, you might recall, failed last September in a trial testing... [[Click headline to continue reading.]]

  • Disease hunting with whole genome sequences: the good news, and the bad news [Genetic Future]

    Updated: 2010-03-10 22:00:00
    : , Now on ScienceBlogs : The Physics of an Inclined Treadmill Last 24 Hrs Life Science Physical Science Environment Humanities Education Politics Medicine Brain Behavior Technology Information Science Jobs Genetic Future Commentary on human genetics and evolution , direct-to-consumer genetic testing , and the personal genomics . industry Latest Posts Archives About Contact Subscribe i Search Profile Daniel MacArthur I write about the genetic and evolutionary basis of human variation , and the companies trying to sell you information about your . genome Subscribe via RSS Follow me on Twitter Recent Posts Disease hunting with whole genome sequences : the good news , and the bad news State of sequencing technology in 2010 Genetic ancestry testing : people who don't want to know On finding folks you know : 23andMe reveals some unexpected cousins The end is nigh for 23andMe New players in sequencing debut at AGBT Pacific Biosciences introduces new third-generation sequencing instrument at AGBT Belated news from AGBT Complete Genomics announces 500 genomes in the pipeline The place to be on April 27th : the Genomes Environments Traits GET Conference Recent Comments Steven Murphy MD on

  • Sr. Research Associate – Temp – BioPhase Solutions Inc – San Diego, CA

    Updated: 2010-03-10 13:10:46
    a leading San Diego biotechnology company. Senior... Research;General/Other: R&D/Science Industry: Biotechnology/Pharmaceuticals View all "BioPhase... From Monster - 10 Mar 2010 13:10:46 GMT - job details - View all San Diego jobs

  • The Changing Landscape of Biotech Valuations (ACOR, CBST, MNKD, INCY, SGEN, ITMN, IPXL, MRX, SVNT, VPHM)

    Updated: 2010-03-10 02:07:55
    Submitted by BioHealth Investor Blog The biotech and biohealth universe is changing in size.  In 2008 and 2009, partly due to mergers and partly due to market valuations, there had become a surprisingly small number of biotech stocks which had market capitalization rates of more than $1 billion.  At one point there were only about 10 [...]

  • Talking Biotech ETFs: iShares Nasdaq Biochnology to $100 (IBB, OSIP, MDVN)

    Updated: 2010-03-06 00:48:35
    Submitted by BioHealth Investor Blog Today’s price moves in the biotech sector are quite different from what we saw earlier this week.  A hostile merger via tender from Astellas for OSI Pharmaceuticals Inc. (NASDAQ: OSIP) got everyone up in arms this week.  So much that other investors were going back over buyout candidate notes.  We also [...]

  • Biotech Implosion: Medivation, Alzheimer’s Beats Drug (MDVN, PFE)

    Updated: 2010-03-06 00:47:37
    Submitted by BioHealth Investor Blog Medivation, Inc. (NASDAQ: MDVN) is the next biotech implosion.  The company’s highly awaited Phase III study on its Alzheimer drug called Dimebon did not meet expectations. It failed to meet primary and secondary endpoints. The problem is that this was hitting 52-week highs yesterday. The company did note that a separate Phase [...]

  • More Biotech Buyout or M&A Targets (OSIP, VRTX, AUXL, ITMN, HGSI, CELG, DNDN, ENZN, FACT, PBE, XBI)

    Updated: 2010-03-03 02:12:37
    Submitted by BioHealth Investor Blog After today’s hostile Astellas offer for OSI Pharmaceuticals (NASDAQ: OSIP), we have investors and traders alike looking for ‘the next takeover target’ in biotech.  Buy now you know that there are many pitfalls in simply looking for biotech stocks to buy because they will be taken over.  We have taken a [...]

  • Hostile Mergers Back in Biotech (OSIP)

    Updated: 2010-03-03 02:07:01
    Submitted by BioHealth Investor Blog Mergers are back in biotech…. Astellas Pharma Inc., a global pharmaceutical company in Japan, announced that it will commence a tender offer to acquire all outstanding shares of common stock of OSI Pharmaceuticals (NASDAQ: OSIP).  The direct tender is nothing short of a hostile merger after Astellas said that OSI has [...]

  • Generic Drug Wars… Is Dr. Reddy’s The Answer? (RDY, TEVA, GSK)

    Updated: 2010-03-01 01:22:42
    Submitted by BioHealth Investor Blog Generic drugs are just one of the many combined issues that are coming front and center in the world of healthcare reform.   Frankly this is not a new notion.  Not all.  This weekend came a feature in Barron’s “Asian Trader: Pill Maker That’s Set To Pop” calling Dr. Reddy’s Laboratories Ltd. [...]

  • Sackler Brothers Ties to Purdue Pharma and Profits

    Updated: 2010-02-27 21:23:34
    Submitted by PharmaGossip   via salem-news.com Pic - Richard Sackler, co-chairman of Stamford, Connecticut based Purdue Pharma and adjunct professor of genetics at Rockefeller University. Visit 1800blogger to see all of our industry leading blogs.

  • PharmedOut Conference: June 25th 2010

    Updated: 2010-02-27 16:25:01
    Submitted by PharmaGossip PharmedOut is pleased to announce a conference. “Prescription for Conflict: Should Industry Fund Continuing Medical Education?” will be held on Friday, June 25, 2010, on the Georgetown campus in Washington DC. We intend to address the questions: Does drug industry funding of CME adversely affect the educational content of CME? If so, can commercial [...]

  • Pfizer - Rapamune: DOJ conducts criminal probe

    Updated: 2010-02-27 03:27:01
    Submitted by PharmaGossip Federal prosecutors in Oklahoma are conducting a criminal investigation of a Pfizer unit’s promotional practices for organ-transplant drug Rapamune, the drug maker disclosed Friday. New York-based Pfizer said in a regulatory filing the U.S. Attorney’s office for the western district of Oklahoma was conducting the probe. There were no further details in the regulatory [...]

  • Celebrating US Whistleblowers

    Updated: 2010-02-25 21:54:52
    Submitted by PharmaGossip   Visit 1800blogger to see all of our industry leading blogs.

  • GSK - Avandia: Harlan Krumholz MD writes in Forbes

    Updated: 2010-02-25 21:32:35
    Submitted by PharmaGossip I want to believe in America’s pharmaceutical companies. I want to believe that people in these companies believe that the best strategy for success is to do what is best for patients. I want to believe that they are interested in scientific truth and eager to know of any safety issues and ready [...]

  • Cost of Cancer

    Updated: 2010-02-24 21:18:22
    Submitted by Health Economics Dear All, please find below link of an interesting piece of work on the cost of cancer in the UK. best Ulf http://www.policyexchange.org.uk/images/publications/pdfs/The_Cost_of_Cancer_-_Feb__10.pdf Visit 1800blogger to see all of our industry leading blogs.

  • Two key Analyst Call in BioHealth Space (DNDN, HGSI)

    Updated: 2010-02-23 04:32:07
    Submitted by BioHealth Investor Blog We have seen two very key biotech analyst calls this morning, and shares of both are responding.  Dendreon Corp. (NASDAQ: DNDN) and Human Genome Sciences (NASDAQ: HGSI) were both given positive brokerage initiations this morning. Dendreon Corp. (NASDAQ: DNDN) is seeing gains this morning after the stock was started as “Overweight” and [...]

  • Life’s smallest motor, cargo carrier of the cells, moves like a seesaw

    Updated: 2010-02-19 15:37:49
    Life’s smallest motor, a protein that shuttles cargo within cells and helps cells divide, does so by rocking up and down like a seesaw, according to research conducted by scientists at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory and Brandeis University. The researchers created high-resolution snapshots of a protein motor, called kinesin, as it [...] (Source: Biosingularity)

  • THE HEALTH ECONOMICS BLOG - Trends, Politics, Opinions etc. in biotech & pharma industry

    Updated: 2010-02-19 01:26:28
    Submitted by THE HEALTH ECONOMICS BLOG … am sure that will be very welcomed news by the consultants among the readers Cheers Ulf Pharmacoeconomics to Get Bigger Budgets, According to Preliminary Survey Results Marketwire News Releases Published: 02/15/10 12:12 PM EST Cutting Edge Information Reports Findings From Ongoing Study RESEARCH TRIANGLE PARK, NC — (Marketwire) — 02/15/10 — This year, drug makers’ [...]

  • Rigel Attacks Rheumatoid Arthritis with AstraZeneca (RIGL, AZN)

    Updated: 2010-02-19 01:25:11
    Submitted by BioHealth Investor Blog Rigel Pharmaceuticals (NASDAQ: RIGL) may be the biotech winner this Tuesday.  The company has signed a pact with AstraZeneca (NYSE: AZN) which could ultimately bring in about $1.25 billion if all targets are met.  This pact is a licensing agreement for Rigel’s rheumatoid arthritis drug R788 or fostamatinib disodium. Rigel said last [...]

  • Further doubt cast on virus link to chronic fatigue

    Updated: 2010-02-16 20:35:36
    Researchers investigating UK samples have found no association between the controversial xenotropic murine leukaemia virus-related virus (XMRV) and chronic fatigue syndrome (CFS). Their study, published in BioMed Central’s open access journal Retrovirology, calls into question a potential link described late last year by an American research team. Kate Bishop from the MRC National Institute for Medical [...] (Source: Biosingularity)

  • Child Obesity Risks Death at Early Age, Study Finds

    Updated: 2010-02-13 23:18:28
    A rare study that tracked thousands of children through adulthood found the heaviest youngsters were more than twice as likely as the thinnest to die prematurely, before age 55, of illness or a self-inflicted injury. Youngsters with a condition called pre-diabetes were at almost double the risk of dying before 55, and those with high blood [...] (Source: Biosingularity)

  • How to Change A Skin Cell Into A Nerve Cell or Cellular Anarchy & The Great Leap Sideways

    Updated: 2010-02-13 23:16:24
    Eyeballs just don’t become toenails — even though the same genome sits in the nucleus of every cell. The difference is in the parts of the genome that are expressed — a cell’s identity is determined by the specific genes that are active within that cell. The differentiation of a cell, and a cell’s commitment [...] (Source: Biosingularity)

  • Think Twice: How the Gut’s “Second Brain” Influences Mood and Well-Being

    Updated: 2010-02-13 23:11:22
    As Olympians go for the gold in Vancouver, even the steeliest are likely to experience that familiar feeling of “butterflies” in the stomach. Underlying this sensation is an often-overlooked network of neurons lining our guts that is so extensive some scientists have nicknamed it our “second brain”. A deeper understanding of this mass of neural tissue, [...] (Source: Biosingularity)

  • Brain surgery boosts spirituality

    Updated: 2010-02-13 22:47:33
    Removing part of the brain can induce inner peace, according to researchers from Italy. Their study provides the strongest evidence to date that spiritual thinking arises in, or is limited by, specific brain areas. To investigate the neural basis of spirituality, Cosimo Urgesi, a cognitive neuroscientist at the University of Udine, and his colleagues turned [...] (Source: Biosingularity)

  • Researchers Discover First Genes for Stuttering

    Updated: 2010-02-13 22:44:58
    Stuttering may be the result of a glitch in the day-to-day process by which cellular components in key regions of the brain are broken down and recycled, says a study in the Feb. 10 Online First issue of the New England Journal of Medicine. The study, led by researchers at the National Institute on Deafness [...] (Source: Biosingularity)

  • New book examines the flawed human body

    Updated: 2010-02-13 22:20:47
    Humanity’s physical design flaws have long been apparent – we have a blind spot in our vision, for instance, and insufficient room for wisdom teeth – but do the imperfections extend to the genetic level? In his new book, Inside the Human Genome, John Avise examines why – from the perspectives of biochemistry and molecular genetics [...] (Source: Biosingularity)

  • Researchers develop dietary formula that maintains youthful function into old age

    Updated: 2010-02-13 22:17:53
    Researchers at McMaster University have developed a cocktail of ingredients that forestalls major aspects of the aging process. “As we all eventually learn, ageing diminishes our mind, fades our perception of the world and compromises our physical capacity,” says David Rollo, associate professor of biology at McMaster. “Declining physical activity—think of grandparents versus toddlers—is one of [...] (Source: Biosingularity)

  • Chocolate lovers could be lowering their risk of stroke

    Updated: 2010-02-13 22:16:26
    Giving chocolates to your Valentine on February 14th may help lower their risk of stroke based on a preliminary study from researchers at St. Michael’s Hospital. The study, which is being presented at the American Academy of Neurology in April, also found that eating chocolate may lower the risk of death after suffering a stroke. “Though [...] (Source: Biosingularity)

  • Scientists synthesize unique family of anti-cancer compounds

    Updated: 2010-02-13 22:14:05
    Yale University scientists have streamlined the process for synthesizing a family of compounds with the potential to kill cancer and other diseased cells, and have found that they represent a unique category of anti-cancer agents. Their discovery appears in this week’s online edition of theJournal of the American Chemical Society. The team studied a family of [...] (Source: Biosingularity)

  • Mediterranean Diet May Prevent Stroke-Related Brain Damage

    Updated: 2010-02-12 03:58:40
    Avoiding potentially dangerous silent strokes may be another health benefit of following a Mediterranean diet. A new study shows people who most closely followed a Mediterranean-style diet were 36% less likely to have areas of brain damage linked to silent strokes than those who least closely followed the diet. These areas of brain damage, called brain [...] (Source: Biosingularity)

  • An Early Warning System for Cancer

    Updated: 2010-02-12 03:56:51
    A new screening tool developed by scientists in Denmark may help detect the earliest stages of cancer by taking advantage of the body’s own defenses. The researchers constructed a microarray system that analyzes patients’ blood for a specific class of immune agents called autoantibodies. These are agents that attack the body’s own tissue, targeting what [...] (Source: Biosingularity)

  • Genetic Testing Heads to the Pharmacy

    Updated: 2010-02-12 03:41:59
    Even though nearly 2,000 genetic tests are available today, most Americans have never taken one. (Save, perhaps, for newborn screening.) That may soon change, as the nation’s largest businesses responsible for managing prescription benefits, Medco and CVS Caremark, delve into the DNA testing business. Taken together, the two companies cover more than 100 million Americans. via [...] (Source: Biosingularity)

Previous Months Items

Feb 2010 | Jan 2010 | Dec 2009 | Nov 2009 | Oct 2009 | Sep 2009